Kevin Coffey is an attorney in the Firm’s Health Care Litigation and Disputes and Government Investigations practice groups, where he represents a wide range of health care and life sciences companies, including hospitals and health systems, medical device and pharmaceutical companies, long-term and post-acute care providers, and pharmacies.

Kevin advises clients on fraud and abuse regulatory and enforcement matters, including investigations and litigation under the False Claims Act, federal and state Anti-Kickback Statutes, Stark Law, and Medicare and Medicaid reimbursement and coverage criteria. He also assists with litigation and investigation avoidance strategy.

Kevin has extensive experience representing clients in investigations conducted by state and federal agencies, including the U.S. Department of Justice, the U.S. Department of Health and Human Services-Office of Inspector General, Medicaid Fraud Control Units, and State Attorneys General.

Particularly well-qualified in matters involving the OIG, Kevin is an expert in navigating issues related to the agency’s exclusion authority and its efforts to place individuals and entities on the excluded provider lists. He has a proven track record of demonstrating to the OIG that Corporate Integrity Agreements are unnecessary in connection with FCA settlements, achieving favorable outcomes for his clients.

In addition, Kevin has developed compliance programs for health systems and national health care providers from the ground up and has worked extensively to improve and enhance existing compliance programs. This experience gives him the credibility and deep knowledge necessary when negotiating with the OIG and other enforcement agencies.

Kevin has litigated dozens of FCA lawsuits in federal district and appellate courts across the country. Outside the health care space, he also advises Fortune 500 companies and spends considerable time matching clients with exceptional attorneys throughout the Firm to meet their unique legal needs promptly and effectively.

Kevin serves as the Pro Bono Coordinator for the Chicago office, where he helps his colleagues vet opportunities, and helps manage the office’s relationships with key organizations.

Kevin resides in Chicago with his wife and young children. He enjoys exploring the city, attending concerts and rooting for his favorite sports teams, including the Chicago Bears. In his free time, he helps coach his kids’ sports teams, fostering teamwork and development both on and off the field.

Read More

Education

  • Loyola University Chicago School of Law (LL.M.)
    • Beazley Institute of Health Law and Policy
  • University of Illinois College of Law (J.D., cum laude)
    • University of Dayton (B.A.)
      • Political Science

    Bar Admission

    • Illinois, 2010

    Court Admissions

    • U.S. District Court, Northern District of Illinois, 2012
    • U.S. Court of Appeals, Third Circuit
    • U.S. Court of Appeals, Fifth Circuit

    Professional Affiliations

    • American Health Law Association
    • Illinois Health Lawyers Association

    Recognition

    • Selected for inclusion in Best Lawyers in America® for Health Care Law, 2026
    • Included in Craine’s Chicago Business list of “Notable Rising Stars in Law,” 2021
    • Named one of Best Lawyers: Ones to Watch® in America in Health Care Law, 2024-2025
    • Elected to the American Bar Foundation Fellows Program, a distinction limited to 1% of lawyers in each jurisdiction
    Publications
    All Publications
    Fraud & Abuse: Recent Trends, Key Developments and What's Next
    Polsinelli proudly introduces its Fraud and Abuse: Recent Trends, Key Developments and What’s Next e-book. This publication is intended to serve as a valuable resource for health care industry stakeholders, aiming to equip you with insight into the past year’s happenings in order to better navigate the complex landscape of health care fraud and abuse enforcement. Drawing upon the decades of experience that Polsinelli’s government investigations team has in defending False Claims Act cases and health care government investigations, we curated the most notable settlements, court decisions and guidance from regulators in 2025.
    Read More
    FCA Recoveries Hit $6.8 Billion as Courts Question the Future of the Qui Tam Authority
    Key Takeaways The Department of Justice reported record-breaking recoveries in False Claims Act cases in FY2025, more than doubling total recoveries from the prior year. As usual, the bulk of that amount resulted from health care cases, although DOJ emphasized its continued focus on other areas, including military procurement, cybersecurity fraud, fraud in pandemic program and enforcement of tariffs. With a record-breaking number of new whistleblower suits filed in 2025, the industry can expect the upward trend in False Claims Act investigations and settlements to continue for years to come. Meanwhile, courts increasingly are confronting arguments challenging the constitutionality of the False Claims Act’s whistleblower provisions. According to DOJ, in FY2025, False Claims Act settlements and judgments totaled an astounding and record-breaking $6.8 billion, more than
    Read More